Session G: HCV Diagnosis and Linkage to Care
| Thursday, September 7, 2017 |
| 9:00 AM - 11:10 AM |
| Manhattan Ballroom |
Speaker
Dr Slim Fourati
Md, Phd
Inserm U955
Novel Diagnostics for HCV Infection: Where are we Now and Where are we Headed?
9:00 AM - 9:25 AMBiography
Slim Fourati is MD, PhD, is a reseacher in virology at University Paris-Est in Paris, France. He is also clinical virologist in the department of Microbiology, Henri Mondor Hospital, Creteil, France. He works in the research group of Pr Jean-Michel PAWLOTSKY to focus his research on HCV diagnosis, drug resistance and HBV pathogenesis and diagnosis
Dr. Stacey Trooskin
Chief Medical Officer
Philadelphia Fight Community Health Centers
Novel Strategies to Enhance Testing and Linkage to HCV Care and Treatment
9:25 AM - 9:50 AMBiography
Stacey Trooskin, MD PhD, is the Director of Viral Hepatitis Programs at Philadelphia FIGHT Health Centers. She received her MPH from Yale University School of Public Health, her medical degree from Robert Wood Johnson Medical School and her PhD from Rutgers School of Public Health. She completed her internal medicine residency and infectious diseases fellowship at the Hospital of the University of Pennsylvania. Her primary research interest focuses on health disparities and developing and evaluating models of HCV care.
Mr Sione Crawford
Health Promotion Worker
Hepatitis Victoria
How to Work with People who Inject Drugs in Building Relevant Models of HCV Care?
9:50 AM - 10:15 AMBiography
For over 14 years Sione Crawford has worked in peer and community organisations committed to preventing and treating hepatitis C in people who inject drugs. He has worked in various roles over this time, including community development, health promotion, peer support and education and management. Sione believes strongly in the role of peers and the affected community in the attempt to eliminate hepatitis C in Australia.
Professor Magdalena Harris
Professor of Inclusion Health Sociology
London School Of Hygiene & Tropical Medicine
Identity Transformations and other Unexpected Benefits of HCV Treatment: A Review of the Evidence and Reflections for the DAA Era
10:15 AM - 10:40 AMBiography
Magdalena Harris is an Associate Professor at the London School of Hygiene and Tropical Medicine where she conducts a programme of research investigating the lived experience of hepatitis C, its treatment and prevention in the UK. Magdalena also has experience of living with, and successfully undergoing treatment for hepatitis C.
Prof Jason Grebely
Professor
UNSW/Kirby Institute
Mrs. Kathleen Ward
Doctoral Student
Drexel University
Randomized Controlled Trial of Cash Incentives or Peer Mentors to Improve HCV Linkage and Treatment among HIV/HCV Coinfected Persons who Inject Drugs: the Champs Study
10:55 AM - 11:10 AMBiography
Kathleen Ward is currently a senior research program coordinator with the Division of Infectious Diseases, Department of Medicine, at Johns Hopkins Medical Institutions. Research interests include the HCV care continuum and linkage to care among vulnerable populations. She holds a Masters of Science in Public Health from the Johns Hopkins Bloomberg School of Public Health in Baltimore, MD.
